After over eighty years of absolute prohibition, the Governing Body opens up to transfusions of individual blood components. The no to whole blood remains. Here’s what really changes in the hospital.
For the first time since the mid-twentieth century, i Jehovah’s Witnesses have substantially modified their doctrinal position on blood transfusions. The announcement came on September 19, 2026 through “2026 Governing Body Update #6”, the sixth video update of the year released by the Governing Body (the body based in New York State that guides the denomination worldwide) and published in multiple languages on the movement’s official website. From today every believer will be able to decide according to individual consciousness whether to accept or donate the four main components of blood: red blood cells, white blood cells, plasma and platelets. However, nothing changes regarding the whole blood taken from another person, the transfusion of which remains prohibited under a literal interpretation of the Bible. To understand the scope of the innovation, we need to start from medical practice. A transfusion consists of transferring blood donated by another person (allogeneic transfusion) or previously taken from the same patient and then returned (autologous transfusion, permitted by Jehovah’s Witnesses since March 2026) into the bloodstream of a patient. The blood collected from a donor, however, is almost always processed in the laboratory: through the centrifugation it is separated into its main components, because modern medicine prefers to administer only what is needed by the individual patient, reducing waste and risks. The transfusions of whole bloodi.e. not separated, are now rare and limited almost only to extreme emergency contexts, such as massive trauma or the military context. The four components have very different functions. THE red blood cells (erythrocytes) carry oxygen and are transfused in cases of severe anemia, hemorrhages or major surgical operations: it is the most used component of all. The plasmathe liquid part of the blood, contains proteins and clotting factors and is used for those suffering from bleeding disorders, extensive burns or severe liver failure. The platelets they are essential for coagulation and are administered especially to cancer and hematology patients, for example during chemotherapy, when the bone marrow produces too few platelets to prevent spontaneous bleeding. THE white blood cells (leukocytes), finally, are the least transfused: they intervene in the immune response and their use, in the form of granulocytes, remains limited to particularly serious and therapy-resistant infections.
Why Jehovah’s Witnesses Rejected Blood: The History of the Rule
The opposition to transfusions did not arise with the discovery of modern transfusion medicine, but has its roots in the years of the Second World Warwhen the official magazine of the movement, The Watchtowerdeveloped a literal interpretation of some biblical passages that invite believers to “abstain from blood”: extending it from the food prohibition of the Old Testament to include any medical use of human blood. Since then, for over eight decades, the refusal of transfusions has become one of the distinctive and most discussed features of confession, so much so as to make Jehovah’s Witnesses almost unique among religions in holding this position so rigidly. The practical consequences have been significant and, in some cases, dramatic. For decades the rule has affected delicate healthcare choices, legal disputes and family affairs, especially when doctors deemed a transfusion necessary to save the life of a patient, sometimes a minor, and parents objected for religious reasons, giving rise to judicial disputes in several countries. Organizations of former faithfulsuch as the Associated Jehovah’s Witnesses for Reform on Blood (AJWRB), which has been calling for the abolition of the ban for years, they estimated approximately 33 thousand deaths between 1961 and 2016 attributable to the refusal of life-saving transfusions. The movement matters today beyond 9 million faithful active in more than 200 countrieswith approximately 1.3 million members in the United States, which gives a measure of how many people around the world are affected, directly or indirectly, by this rule.
What really changes now, between whole blood and individual components
The turning point of September 2026 did not arrive suddenly, but is the second step in a journey started a few months earlier. Already a March 2026in fact, the Governing Body had authorized theautotransfusionallowing patients to have their blood drawn and stored in advance and then reused, for example in view of a scheduled surgery with the risk of significant blood loss. On that occasion, a member of the Governing Body, Gerrit Lösch, explained in an official video that “every Christian must personally decide how their blood will be used in every medical and surgical treatment”. The September update extends this principle freedom of conscience also to blood coming from other people, but only for its separate components: red blood cells, white blood cells, plasma and platelets. However, the ban on whole blood received from an external donor: a distinction which, from a clinical point of view, has a relative weight, since, as mentioned, the vast majority of transfusions practiced today in hospitals still concern individual components and not unfractionated blood.
Also on the front of donation the novelty has a concrete implication: a faithful will now be able to choose to donate their blood knowing that, in the laboratory, they will almost certainly be subjected to routine separation procedures. However, it remains to be clarified, as some observers have observed, whether an explicit guarantee from the transfusion center on the destination of the donated blood is necessary. In the official communication, the Governing Body nevertheless insisted that “life and blood remain sacred” and that the basic principle has not changed: if anything, the boundaries within which each believer can today exercise his or her conscience in the medical field are changing. Among them former members of the movement, who have long denounced the consequences of the old ban, the reaction has been ambivalent: there are those who have defined the change as “significant” but “not sufficient”, underlining that in emergency situations with serious blood loss, or in pediatric oncology treatments that require multiple transfusions, freedom of choice remains conditioned by the continuation of the ban on whole blood.
